These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12648234

  • 1. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P.
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [Abstract] [Full Text] [Related]

  • 2. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P.
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [Abstract] [Full Text] [Related]

  • 3. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
    Wolf P, Kreimer-Erlacher H, Seidl H, Bäck B, Soyer HP, Kerl H.
    J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
    [Abstract] [Full Text] [Related]

  • 4. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P.
    Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
    [Abstract] [Full Text] [Related]

  • 5. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
    Nataraj AJ, Wolf P, Cerroni L, Ananthaswamy HN.
    J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
    [Abstract] [Full Text] [Related]

  • 6. INK4a-ARF mutations in skin carcinomas from UV irradiated hairless mice.
    Soufir N, Queille S, Mollier K, Roux E, Sarasin A, de Gruijl FR, Fourtanier AM, Daya-Grosjean L, Basset-Seguin N.
    Mol Carcinog; 2004 Apr; 39(4):195-8. PubMed ID: 15057871
    [Abstract] [Full Text] [Related]

  • 7. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Röwert-Huber J, Eberle J, Stockfleth E, Forschner T.
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [Abstract] [Full Text] [Related]

  • 14. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 15. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L, Surin K, Ton TV, Clayton N, Dunnick JK, Kim Y, Hong HH, Devereux TR, Sills RC.
    Toxicol Pathol; 2005 Oct 25; 33(2):292-9. PubMed ID: 15902973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 20. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
    Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN.
    J Invest Dermatol; 2002 Aug 02; 119(2):522-6. PubMed ID: 12190879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.